416 related articles for article (PubMed ID: 16628714)
41. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.
Sivgin S; Karakus E; Keklik M; Zararsiz G; Solmaz M; Kaynar L; Eser B; Cetin M; Unal A
Transfus Apher Sci; 2016 Jun; 54(3):410-5. PubMed ID: 27052362
[TBL] [Abstract][Full Text] [Related]
42. Role of carbohydrate moiety in granulocyte colony stimulating factor.
Sakagami H; Tajima M; Takayama F; Oi T; Kusama K; Yamamoto T; Saito M; Murayama J
Anticancer Res; 2000; 20(4):2355-9. PubMed ID: 10953296
[TBL] [Abstract][Full Text] [Related]
43. Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.
Nolan L; Lorigan P; Chilton S; Newman J; Else R; Smith P; Linch D; Sweetenham JW; Johnson PW
Br J Haematol; 2007 Jun; 137(5):436-42. PubMed ID: 17433027
[TBL] [Abstract][Full Text] [Related]
44. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
Höglund M
Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
[TBL] [Abstract][Full Text] [Related]
45. Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.
Keating GM
Drugs; 2011 Apr; 71(6):679-707. PubMed ID: 21504247
[TBL] [Abstract][Full Text] [Related]
46. Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests.
Sun LX; Ren HY; Shi YJ; Wang LH; Qiu ZX
Biol Blood Marrow Transplant; 2009 Jul; 15(7):835-43. PubMed ID: 19539215
[TBL] [Abstract][Full Text] [Related]
47. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.
Kopf B; De Giorgi U; Vertogen B; Monti G; Molinari A; Turci D; Dazzi C; Leoni M; Tienghi A; Cariello A; Argnani M; Frassineti L; Scarpi E; Rosti G; Marangolo M
Bone Marrow Transplant; 2006 Sep; 38(6):407-12. PubMed ID: 16951690
[TBL] [Abstract][Full Text] [Related]
48. Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Nakasone H; Kanda Y; Ueda T; Matsumoto K; Shimizu N; Minami J; Sakai R; Hagihara M; Yokota A; Oshima K; Tsukada Y; Tachibana T; Nakaseko C; Fujisawa S; Yano S; Fujita H; Takahashi S; Kanamori H; Okamoto S;
Am J Hematol; 2009 Dec; 84(12):809-14. PubMed ID: 19862826
[TBL] [Abstract][Full Text] [Related]
49. Glycosylation interference on RhoA activation: focus on G-CSF.
Mattii L; Battolla B; Azzarà A; D'Urso G; Montali U; Petrini M
Leuk Res; 2011 Feb; 35(2):265-7. PubMed ID: 20573400
[TBL] [Abstract][Full Text] [Related]
50. Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
Azzarà A; Carulli G; Rizzuti-Gullaci A; Capochiani E; Petrini M
Am J Hematol; 2001 Apr; 66(4):306-7. PubMed ID: 11279646
[No Abstract] [Full Text] [Related]
51. Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective study of 126 patients.
Lefrère F; Bernard M; Audat F; Cavazzana-Calvo M; Belanger C; Hermine O; Arnulf B; Buzyn A; Varet B
Leuk Lymphoma; 1999 Nov; 35(5-6):501-5. PubMed ID: 10609787
[TBL] [Abstract][Full Text] [Related]
52. Granulocyte colony-stimulating factor after autologous CD34+ immunoselected peripheral blood stem cell transplantation.
Piccirillo N; De Matteis S; Sorà F; d'Onofrio G; Leone G; Sica S
Haematologica; 2004 Sep; 89(9):1144-6. PubMed ID: 15377480
[TBL] [Abstract][Full Text] [Related]
53. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H
Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089
[TBL] [Abstract][Full Text] [Related]
54. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
[TBL] [Abstract][Full Text] [Related]
55. Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.
Orciuolo E; Buda G; Marturano E; Mauro E; Milone G; Cangialosi C; Di Renzo N; Pastore D; Specchia G; De Paolis MR; Mazza P; Pietrantuono G; Petrini M
Leuk Res; 2011 Jul; 35(7):899-903. PubMed ID: 21134693
[TBL] [Abstract][Full Text] [Related]
56. Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors.
Pérez-López O; Martín-Sánchez J; Parody-Porras R; Espigado-Tocino I; Noguerol P; Carmona-González M; Pérez-Simón JA
Transfusion; 2013 Dec; 53(12):3240-2. PubMed ID: 23489237
[TBL] [Abstract][Full Text] [Related]
57. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
[TBL] [Abstract][Full Text] [Related]
58. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist.
Rutella S; Rumi C; Testa U; Sica S; Teofili L; Martucci R; Peschle C; Leone G
Bone Marrow Transplant; 1997 Sep; 20(5):355-64. PubMed ID: 9339749
[TBL] [Abstract][Full Text] [Related]
60. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production.
Decleva E; Cramer R; Zabucchi G
Int J Tissue React; 1995; 17(5-6):191-8. PubMed ID: 8835629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
